Oral Fluid Sars-CoV-2 Ab Rapid test
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/026044
- Lead Sponsor
- Asian Healthcare Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 140
Inclusion Criteria
1. 18 years or older, men and women
2. Subjects suspected or with symptoms of Sars-CoV-2
3. Subjects, 3 days after the onset of symptoms
4. Smoking or non-smoking
5. Subjects willing for participating in the study and providing informed consent
Exclusion Criteria
Subjects on ventilators or lung support
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There is a significant positive correlation between presence or absence of (blood and salivary) antibodies (against Sars-CoV-19 virus) and, severity and duration of disease after onset of symptoms.Timepoint: 4 July - 19 August 2020
- Secondary Outcome Measures
Name Time Method It is also hypothesized that there is a significant positive correlation between presence or absence of (blood and salivary) antibodies (against Sars-CoV-19 virus) and, severity and duration of disease.Timepoint: 4 July - 19 August 2020